Ascendis Pharma A/S
ASND
33 hedge funds and large institutions have $158M invested in Ascendis Pharma A/S in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 8 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
8% more capital invested
Capital invested by funds: $146M → $158M (+$12M)
8% less funds holding
Funds holding: 36 → 33 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
Top Buyers
Top Sellers
ASND Hedge Fund Activity: Q2 2015 in Review
33 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Ascendis Pharma A/S (ASND) for Q2 2015, worth a combined $158M — up 8.2% from $146M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ASND and 5 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was RA Capital Management, adding an estimated $15.6M. The largest seller was Sectoral Asset Management, cutting an estimated $8.68M.
- 33 institutional investors held Ascendis Pharma A/S (ASND) as of Q2 2015, down from 36 in Q1 2015.
- Funds reported $158M of Ascendis Pharma A/S stock for Q2 2015, up 8.2% quarter-over-quarter.
- 5 funds opened new Ascendis Pharma A/S positions in Q2 2015 and 8 closed out, a net change of -3 holders.
- The largest Ascendis Pharma A/S buyer in Q2 2015 was RA Capital Management, an estimated $15.6M added.
- The largest Ascendis Pharma A/S seller in Q2 2015 was Sectoral Asset Management, an estimated $8.68M sold.
Based on aggregated 13F filings for Q2 2015.